Humacyte Share Price Today (NASDAQ: HUMA)

Name: Humacyte Share Price (NASDAQ: HUMA) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Humacyte share price is $2.38 & ₹204.83 as on 15 Jun 2025, 2.30 'hrs' IST

$2.38

▲

-0.03

(-1.24%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Humacyte share price in Dollar and Rupees. Guide to invest in Humacyte stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Humacyte, along with analyst recommendations, forecasts, and comprehensive financials.

Humacyte share price movements

Today's Low: $2.31
Today's High: $2.46
$2.38
3.15%
Downside
Day's Volatility :6.11%
Upside
3.05%
52 Weeks Low: $1.15
52 Weeks High: $9.79
$2.38
51.68%
Downside
52 Weeks Volatility :88.25%
Upside
75.69%

Humacyte (HUMA) Returns

Period	Humacyte Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.1%	-6.1%	0.0%
6 Months	-45.28%	-3.4%	0.0%
1 Year	-61.63%	-6.7%	0.0%
3 Years	-34.03%	11.8%	2.2%

Humacyte (HUMA) Key Statistics

in dollars & INR

Previous Close	$2.41
Open	$2.31
Today's High	$2.455
Today's Low	$2.305
Market Capitalization	$394.0M
Today's Volume	$2.7M
52 Week High	$9.79
52 Week Low	$1.15
Revenue TTM	$517.0K
EBITDA	$-103.8M
Earnings Per Share (EPS)	$-0.68
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-249.75%

How to invest in Humacyte Stock (HUMA) from India?

It is very easy for Indian residents to invest directly in Humacyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Humacyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Humacyte or HUMA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Humacyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Humacyte shares which would translate to 0.362 fractional shares of Humacyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Humacyte, in just a few clicks!

Returns in Humacyte (HUMA) for Indian investors in Rupees

The Humacyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Humacyte investment value today

Current value as on today

₹41,488

Returns

₹58,512

(-58.51%)

Returns from Humacyte Stock

₹61,551 (-61.55%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Humacyte (HUMA)

26%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Humacyte Stock from India on INDmoney has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Humacyte

BlackRock Inc
5.30%
Vanguard Group Inc
4.25%
State Street Corp
2.75%
Heights Capital Management Inc
2.59%
Woodline Partners LP
2.55%
RA Capital Management, LLC
2.14%

Analyst Recommendation on Humacyte

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Humacyte(by analysts ranked 0 to 5 stars)

Analyst Forecast on Humacyte Stock (HUMA)

What analysts predicted

Upside of 296.16%

Target:

$9.43

Current:

$2.38

Insights on Humacyte Stock (Ticker Symbol: HUMA)

Price Movement
In the last 1 month, HUMA stock has moved up by 25.7%
Decreasing Revenue
Revenue is down for the last 3 quarters, 10.79M → 517.0K (in $), with an average decrease of 62.9% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -56.66M → 39.13M (in $), with an average increase of 95.1% per quarter
HUMA vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 158.0%
Price to Sales
ForHUMA every $1 of sales, investors are willing to pay $593.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Humacyte Technicals Summary

Sell

Neutral

Buy

Humacyte is currently in a neutral trading position according to technical analysis indicators.

Humacyte (HUMA) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Humacyte Inc	6.03%	-45.28%	-61.63%	-34.03%	-34.03%
Regeneron Pharmaceuticals, Inc.	-11.02%	-27.05%	-49.42%	-5.02%	-10.81%
Beone Medicines Ltd	18.08%	52.93%	69.2%	101.57%	55.67%
Vertex Pharmaceuticals Incorporated	3.86%	-2.68%	-3.83%	81.53%	66.4%
Alnylam Pharmaceuticals, Inc.	7.76%	26.01%	95.45%	128.04%	132.45%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Humacyte Inc	1.0	NA	NA	-0.32	-2.5	-0.43	NA	0.23
Regeneron Pharmaceuticals, Inc.	13.31	13.31	1.07	35.45	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.39	-0.11	-0.03	NA	32.42
Vertex Pharmaceuticals Incorporated	32.84	NA	2.66	18.0	-0.06	0.12	NA	64.2
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.93	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Humacyte Inc	Buy	$394.0M	-34.03%	1.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$56.0B	-10.81%	13.31	31.94%
Beone Medicines Ltd	NA	$32.0B	55.67%	NA	-9.4%
Vertex Pharmaceuticals Incorporated	Buy	$116.2B	66.4%	32.84	-8.91%
Alnylam Pharmaceuticals, Inc.	Buy	$38.9B	132.45%	NA	-11.49%

About Humacyte

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Organization	Humacyte
Employees	218
CEO	Dr. Laura E. Niklason M.D., Ph.D.
Industry	Healthcare

Management People of Humacyte

Name	Title
Dr. Laura E. Niklason M.D., Ph.D.	Founder, President, CEO & Director
Mr. Dale A. Sander	CFO, Chief Corporate Development Officer & Treasurer
Dr. Heather Ledbetter Prichard Ph.D.	Chief Operating Officer
Ms. Sabrina Osborne GPHR, SPHR	Chief People Officer
Mr. William John Scheessele	Chief Commercial Officer
Dr. Shamik J. Parikh M.D.	Chief Medical Officer
Dr. Yang Cao M.D., Ph.D.	Chief Regulatory Officer

Important FAQs about investing in HUMA Stock from India :

Can Indians buy Humacyte shares?

Yes, Indians can invest in the Humacyte (HUMA) from India.

With INDmoney, you can buy Humacyte at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Humacyte at zero transaction cost.

How can I buy Humacyte shares from India?

It is very easy to buy Humacyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Humacyte (HUMA) be purchased?

Yes, you can buy fractional shares of Humacyte with INDmoney app.

What are the documents required to start investing in Humacyte stocks?

To start investing in Humacyte, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Humacyte share price today?

Humacyte share price today stands at $2.38, Open: $2.31 ; Previous Close: $2.41 ; High: $2.46 ; Low: $2.31 ; 52 Week High: $9.79 ; 52 Week Low: $1.15.

The stock opens at $2.31, after a closing price of $2.41. The stock reached a daily high of $2.46 and a low of $2.31, with a 52-week high of $9.79 and a 52-week low of $1.15.